Charles River Laboratories International (CRL) Revenue (2016 - 2025)
Historic Revenue for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $1.0 billion.
- Charles River Laboratories International's Revenue fell 48.64% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year decrease of 91.63%. This contributed to the annual value of $4.0 billion for FY2024, which is 192.33% down from last year.
- Latest data reveals that Charles River Laboratories International reported Revenue of $1.0 billion as of Q3 2025, which was down 48.64% from $1.0 billion recorded in Q2 2025.
- In the past 5 years, Charles River Laboratories International's Revenue ranged from a high of $1.1 billion in Q4 2022 and a low of $824.6 million during Q1 2021
- Moreover, its 5-year median value for Revenue was $1.0 billion (2025), whereas its average is $985.1 million.
- Per our database at Business Quant, Charles River Laboratories International's Revenue skyrocketed by 3399.19% in 2021 and then crashed by 785.27% in 2023.
- Over the past 5 years, Charles River Laboratories International's Revenue (Quarter) stood at $905.0 million in 2021, then increased by 21.52% to $1.1 billion in 2022, then fell by 7.85% to $1.0 billion in 2023, then fell by 1.08% to $1.0 billion in 2024, then rose by 0.23% to $1.0 billion in 2025.
- Its Revenue stands at $1.0 billion for Q3 2025, versus $1.0 billion for Q2 2025 and $984.2 million for Q1 2025.